Paper36937395
Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer.
Koc ZC and 4 others. Front Oncol, 2023. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer. Papers, record 36937395. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937395
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P20 GM103434 | NIGMS NIH HHS | United States | P20GM103434 | PubMed | NIH RePORTER |
| U54 GM104942 | NIGMS NIH HHS | United States | U54GM104942 | PubMed | NIH RePORTER |
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17372612 | PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. | Cell Res | 2007 | https://conductscience.org/library/papers/17372612 | PubMed |
| 2 | 35326551 | Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35326551 | PubMed |
| 3 | 23908630 | Identification and characterization of CHCHD1, AURKAIP1, and CRIF1 as new members of the mammalian mitochondrial ribosome. | Front Physiol | 2013 | https://conductscience.org/library/papers/23908630 | PubMed |
| 4 | 28821788 | Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells. | Sci Rep | 2017 | https://conductscience.org/library/papers/28821788 | PubMed |
| 5 | 25243473 | Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma. | PLoS One | 2014 | https://conductscience.org/library/papers/25243473 | PubMed |
| 6 | 23839242 | Evaluating cell lines as tumour models by comparison of genomic profiles. | Nat Commun | 2013 | https://conductscience.org/library/papers/23839242 | PubMed |
| 7 | 8965693 | In vivo labeling and analysis of human mitochondrial translation products. | Methods Enzymol | 1996 | https://conductscience.org/library/papers/8965693 | PubMed |
| 8 | 31699970 | Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31699970 | PubMed |
| 9 | 35842901 | Mitochondrial DNA mutations in ageing and cancer. | Mol Oncol | 2022 | https://conductscience.org/library/papers/35842901 | PubMed |
| 10 | 33663122 | A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate. | Medicine (Baltimore) | 2021 | https://conductscience.org/library/papers/33663122 | PubMed |
| 11 | 19366681 | Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19366681 | PubMed |
| 12 | 17562866 | Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. | Mol Cell Biol | 2007 | https://conductscience.org/library/papers/17562866 | PubMed |
| 13 | 30030363 | Mitochondrial transcription and translation: overview. | Essays Biochem | 2018 | https://conductscience.org/library/papers/30030363 | PubMed |
| 14 | 2169892 | The translation system of mammalian mitochondria. | Biochim Biophys Acta | 1990 | https://conductscience.org/library/papers/2169892 | PubMed |
| 15 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 16 | 23155235 | Initial activation status of the antioxidant response determines sensitivity to carboplatin/paclitaxel treatment of ovarian cancer. | Anticancer Res | 2012 | https://conductscience.org/library/papers/23155235 | PubMed |
| 17 | 26238294 | Impaired mitochondrial protein synthesis in head and neck squamous cell carcinoma. | Mitochondrion | 2015 | https://conductscience.org/library/papers/26238294 | PubMed |
| 18 | 12075011 | Nuclear genetic control of mitochondrial translation in skeletal muscle revealed in patients with mitochondrial myopathy. | Hum Mol Genet | 2002 | https://conductscience.org/library/papers/12075011 | PubMed |
| 19 | 27977010 | TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. | Cell Death Dis | 2016 | https://conductscience.org/library/papers/27977010 | PubMed |
| 20 | 33934540 | MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer. | Cancer Med | 2021 | https://conductscience.org/library/papers/33934540 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42568094 | DARS2 Promotes Tumorigenesis and Metastasis by Activating PI3K/Akt/GSK-3β/β-Catenin Signaling Pathway in Breast Cancer. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/42568094 | PubMed |
| 42164352 | DARS2 serves as an independent prognostic factor and participates in multiple biological processes in bladder urothelial carcinoma. | Transl Androl Urol | 2026 | https://conductscience.org/library/papers/42164352 | PubMed |
| 41899413 | Mitochondrial Long Non-Coding RNAs in Gynecological Cancers: Pathogenic Signaling Pathways and Therapeutic Opportunities. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41899413 | PubMed |
| 41884555 | The uterine secretome initiates growth of gynecologic tissues in ectopic locations: re-evaluating the evidence. | Pathol Oncol Res | 2026 | https://conductscience.org/library/papers/41884555 | PubMed |
| 41722873 | Recovery from chronic PFAS exposure can reverse chemotherapy resistance and mitochondrial alterations in ovarian cancer cells. | Toxicol Lett | 2026 | https://conductscience.org/library/papers/41722873 | PubMed |
| 41516218 | Subcellular Stress Markers in Epithelial Ovarian Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516218 | PubMed |
| 41226512 | Cellular cAMP Content and Mitochondrial Profile Define Different Subtypes of Ovarian Cancer Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226512 | PubMed |
| 40989573 | Free Radicals in Health and Disease. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40989573 | PubMed |
| 40861078 | Metabolic Reprogramming Shapes the Progression and Therapeutic Landscape of Ovarian Cancer. | Cancer Manag Res | 2025 | https://conductscience.org/library/papers/40861078 | PubMed |
| 40563592 | The Identification of a Key Regulator of Mitochondrial Metabolism, the LRPPRC Protein, as a Novel Therapeutic Target in SDHA-Overexpressing Ovarian Tumors. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40563592 | PubMed |
| 39927160 | Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma. | Open Med (Wars) | 2025 | https://conductscience.org/library/papers/39927160 | PubMed |
| 39543742 | Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors. | J Ovarian Res | 2024 | https://conductscience.org/library/papers/39543742 | PubMed |
| 39143326 | Deregulation of mitochondrial gene expression in cancer: mechanisms and therapeutic opportunities. | Br J Cancer | 2024 | https://conductscience.org/library/papers/39143326 | PubMed |
| 38868764 | TUFM in health and disease: exploring its multifaceted roles. | Front Immunol | 2024 | https://conductscience.org/library/papers/38868764 | PubMed |
| 38382106 | Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38382106 | PubMed |
| 38193640 | Mutational profiling of mitochondrial DNA reveals an epithelial ovarian cancer-specific evolutionary pattern contributing to high oxidative metabolism. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/38193640 | PubMed |
| 37626419 | DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma. | J Transl Med | 2023 | https://conductscience.org/library/papers/37626419 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36937395
GET https://conductscience.org/api/papers/v1/36937395/references?page=2